DLGAP5P2

Across TCGA pan-cancer cohorts, DLGAP5P2 RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated DLGAP5P2 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher DLGAP5P2 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated DLGAP5P2 expression acts as an unfavorable survival marker, although some lineages such as OV and ESCA show a favorable association.

OV, DLBC, and ESCA are the cancer types where DLGAP5P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Tertile	III,IV	0.373	0.147	.017	36	view →
DLBC	DFS	Tertile	II,III,IV	0.022	0.837	<.001	36	view →
ESCA	OS	Tertile	III,IV	1.000	0.370	.028	18	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

DLGAP5P2–OV (DFS)

Open the OV breakdown →